These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15970117)

  • 21. [Percutaneous coronary revascularization in patients over eighty: acute and long-term results].
    Lettieri C; Buffoli F; Romano M; Aroldi M; Baccaglioni N; Tomasi L; Rosiello R; Agostini F; Kuwornu H; Pepi P; Izzo A; Zanini R
    Ital Heart J Suppl; 2005 Sep; 6(9):588-98. PubMed ID: 16281718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
    Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
    Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Grade 3 ischemia on the admission electrocardiogram predicts failure of ST resolution and of adequate flow restoration after primary percutaneous coronary intervention for acute myocardial infarction.
    Wolak A; Yaroslavtsev S; Amit G; Birnbaum Y; Cafri C; Atar S; Gilutz H; Ilia R; Zahger D
    Am Heart J; 2007 Mar; 153(3):410-7. PubMed ID: 17307421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of the presence of peripheral vascular disease in predicting mortality in acute myocardial infarction patients treated with primary angioplasty (from the Primary Angioplasty in Myocardial Infarction Database).
    Guerrero M; Harjai K; Stone GW; Brodie B; Cox D; Boura J; Grines L; O'Neill W; Grines C
    Am J Cardiol; 2005 Sep; 96(5):649-54. PubMed ID: 16125488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial-dependent vasoconstriction in the infarct-related artery early after myocardial infarction is smaller following primary angioplasty than thrombolytic therapy.
    González-Costello J; Iràculis E; Gómez-Hospital JA; Maristany J; Jara F; Espulgas E; Cequier A
    Rev Esp Cardiol; 2008 Aug; 61(8):817-24. PubMed ID: 18684364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Death after ST-elevation myocardial infarction in patients treated with fibrinolytic therapy, angioplasty, or conventional therapy. A post-mortem study to verify cardiac rupture as a cause of death].
    Fornaro G; Lazzero M; Giacalone A; Aralda D; Prando MD; Rossi L; Bongo AS
    G Ital Cardiol (Rome); 2008 Jun; 9(6):408-20. PubMed ID: 18681392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of preconditioning and postconditioning on emergency percutaneous coronary intervention in patients with acute myocardial infarction].
    Ma XJ; Zhang XH; Luo M; Li CM; Shao JH
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):114-7. PubMed ID: 17418019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
    Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
    Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA;
    Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
    Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G
    Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Delays of treatment of acute myocardial infarction with ST elevation admitted to the CCU (coronary care unit) in Alsace].
    Thorn S; Attali P; Boulenc JM; Gladin M; Monassier JP; Roul G; Sussmann C; Zaehringer M; Zelinsky R; Zupan M
    Arch Mal Coeur Vaiss; 2007 Jan; 100(1):7-12. PubMed ID: 17405548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome.
    Kilic T; Ural D; Ural E; Yumuk Z; Agacdiken A; Sahin T; Kahraman G; Kozdag G; Vural A; Komsuoglu B
    Heart; 2006 Aug; 92(8):1041-6. PubMed ID: 16547209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble CD40 ligand:interleukin-10 ratio predicts in-hospital adverse events in patients with ST-segment elevation myocardial infarction.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
    Thromb Res; 2007; 121(3):293-9. PubMed ID: 17521712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of clinically defined spontaneous reperfusion to outcome in ST-elevation myocardial infarction.
    Fefer P; Hod H; Hammerman H; Boyko V; Behar S; Matetzky S;
    Am J Cardiol; 2009 Jan; 103(2):149-53. PubMed ID: 19121427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
    Marso SP; Miller T; Rutherford BD; Gibbons RJ; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Mehran R; Krucoff MW; Lansky AJ; Stone GW
    Am J Cardiol; 2007 Jul; 100(2):206-10. PubMed ID: 17631071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of acute ST-elevation myocardial infarction in the coronary care units of Piedmont in 2005: results from the PRIMA regionwide survey.
    Steffenino G; Chinaglia A; Millesimo G; Gnavi R; Picariello R; Orlando A;
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):169-77. PubMed ID: 18192810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of impaired myocardial reperfusion on left ventricular remodeling in patients with anterior wall acute myocardial infarction treated with primary coronary intervention.
    Araszkiewicz A; Grajek S; Lesiak M; Prech M; Pyda M; Janus M; Cieslinski A
    Am J Cardiol; 2006 Sep; 98(6):725-8. PubMed ID: 16950171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of coronary flow reserve immediately after primary coronary angioplasty for acute myocardial infarction in predicting long-term adverse cardiac events.
    Takahashi T; Hiasa Y; Ohara Y; Miyazaki S; Ogura R; Miyajima H; Yuba K; Suzuki N; Hosokawa S; Kishi K; Ohtani R
    Am J Cardiol; 2007 Sep; 100(5):806-11. PubMed ID: 17719324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.